How genomic testing can address accuracy issues with PSA screening and monitoring

Video
Around the Practice

Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, discusses how the precision of genomic testing data can alleviate the accuracy issues associated with PSA testing for screening and monitoring prostate cancer.

Related Videos
Expert on prostate cancer
Expert on prostate cancer
Expert on prostate cancer
Experts on prostate cancer
Around the Practice July 21, 2021: Bladder Cancer Cases
Genetic, Genomic Testing in Heavily Treated, Metastatic Castrate-Resistant Prostate Cancer
Genetic, Genomic Testing in Newly Diagnosed, High-Grade, High-Risk Prostate Cancer
Related Content

Around the Practice: The Management of Biochemical Recurrence in Prostate Cancer

May 6th 2021

Around the Practice: The Management of Biochemical Recurrence in Prostate Cancer

May 6th 2021

Around the Practice: The Management of Biochemical Recurrence in Prostate Cancer

May 6th 2021
© 2023 MJH Life Sciences

All rights reserved.